Nitric oxide synthase and neuronal vulnerability in parkinson's disease
Identifieur interne : 002155 ( Main/Exploration ); précédent : 002154; suivant : 002156Nitric oxide synthase and neuronal vulnerability in parkinson's disease
Auteurs : S. Hunot [France] ; F. Boissière [France] ; B. Faucheux [France] ; B. Brugg [France] ; A. Mouatt-Prigent [France] ; Yves Agid [France] ; E. C. Hirsch [France]Source :
- Neuroscience [ 0306-4522 ] ; 1995.
English descriptors
- KwdEn :
Abstract
Parkinson's disease is characterized by a loss of dopaminergic neurons in the mesencephalon. Although the mechanism of this neuronal loss is still unknown, oxidative stress is very likely involved in the cascade of events leading to nerve cell death. Since nitric oxide could be involved in the production of free radicals, we analysed, using immunohistochemistry and histochemistry, the production systems of nitric oxide in the mesencephalon of four patients with idiopathic Parkinson's disease and three matched control subjects. Using specific antibodies directed against the inducible isoform of nitric oxide synthase (the enzyme involved in the synthesis of nitric oxide), we found evidence to suggest that this isoform was present solely in glial cells displaying the morphological characteristics of activated macrophages. Immunohistochemical analysis performed with antibodies against the neuronal isoform of nitric oxide synthase, however, revealed perikarya and processes of neurons but no glial cell staining. The number of nitric oxide synthase-containing cells was investigated by histoenzymology, using the NADPH-diaphorase activity of nitric oxide synthase. Histochemistry revealed (i) a significant increase in NADPH-diaphorasepositive glial cell density in the dopaminergic cell groups characterized by neuronal loss in Parkinson's disease and (ii) a neuronal loss in Parkinson's disease that was two-fold greater for pigmented NADPH-diaphorase-negative neurons than for pigmented NADPH-diaphorase-positive neurons.These data suggest a potentially deleterious role of glial cells producing excessive levels of nitric oxide in Parkinson's disease, which may be neurotoxic for a subpopulation of dopaminergic neurons, especially those not expressing NADPH-diaphorase activity. However, it cannot be excluded that the presence of glial cells expressing nitric oxide synthase in the substantia nigra of patients with Parkinson's disease represents a consequence of dopaminergic neuronal loss.
Url:
DOI: 10.1016/0306-4522(95)00578-1
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Nitric oxide synthase and neuronal vulnerability in parkinson's disease</title><author><name sortKey="Hunot, S" sort="Hunot, S" uniqKey="Hunot S" first="S." last="Hunot">S. Hunot</name></author><author><name sortKey="Boissiere, F" sort="Boissiere, F" uniqKey="Boissiere F" first="F." last="Boissière">F. Boissière</name></author><author><name sortKey="Faucheux, B" sort="Faucheux, B" uniqKey="Faucheux B" first="B." last="Faucheux">B. Faucheux</name></author><author><name sortKey="Brugg, B" sort="Brugg, B" uniqKey="Brugg B" first="B." last="Brugg">B. Brugg</name></author><author><name sortKey="Mouatt Prigent, A" sort="Mouatt Prigent, A" uniqKey="Mouatt Prigent A" first="A." last="Mouatt-Prigent">A. Mouatt-Prigent</name></author><author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name><affiliation><country>France</country><placeName><settlement type="city">Paris</settlement><region type="region" nuts="2">Île-de-France</region></placeName><orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName></affiliation></author><author><name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E. C." last="Hirsch">E. C. Hirsch</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B157D8785BAACB7BB3EC52E539A7FBA2A93B5D7C</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1016/0306-4522(95)00578-1</idno><idno type="url">https://api.istex.fr/document/B157D8785BAACB7BB3EC52E539A7FBA2A93B5D7C/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001731</idno><idno type="wicri:Area/Main/Curation">001494</idno><idno type="wicri:Area/Main/Exploration">002155</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Nitric oxide synthase and neuronal vulnerability in parkinson's disease</title><author><name sortKey="Hunot, S" sort="Hunot, S" uniqKey="Hunot S" first="S." last="Hunot">S. Hunot</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>INSERM U289, Physiopathologie et Pathogenèse des Maladies Dégénératives du Système Nerveux, Hoˆpital de la Salpêtrière, 47 bd de l'Hoˆpital, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Boissiere, F" sort="Boissiere, F" uniqKey="Boissiere F" first="F." last="Boissière">F. Boissière</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>INSERM U289, Physiopathologie et Pathogenèse des Maladies Dégénératives du Système Nerveux, Hoˆpital de la Salpêtrière, 47 bd de l'Hoˆpital, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Faucheux, B" sort="Faucheux, B" uniqKey="Faucheux B" first="B." last="Faucheux">B. Faucheux</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>INSERM U289, Physiopathologie et Pathogenèse des Maladies Dégénératives du Système Nerveux, Hoˆpital de la Salpêtrière, 47 bd de l'Hoˆpital, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Brugg, B" sort="Brugg, B" uniqKey="Brugg B" first="B." last="Brugg">B. Brugg</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>INSERM U289, Physiopathologie et Pathogenèse des Maladies Dégénératives du Système Nerveux, Hoˆpital de la Salpêtrière, 47 bd de l'Hoˆpital, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Mouatt Prigent, A" sort="Mouatt Prigent, A" uniqKey="Mouatt Prigent A" first="A." last="Mouatt-Prigent">A. Mouatt-Prigent</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>INSERM U289, Physiopathologie et Pathogenèse des Maladies Dégénératives du Système Nerveux, Hoˆpital de la Salpêtrière, 47 bd de l'Hoˆpital, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>INSERM U289, Physiopathologie et Pathogenèse des Maladies Dégénératives du Système Nerveux, Hoˆpital de la Salpêtrière, 47 bd de l'Hoˆpital, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName><placeName><settlement type="city">Paris</settlement><region type="region" nuts="2">Île-de-France</region></placeName><orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName></affiliation></author><author><name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E. C." last="Hirsch">E. C. Hirsch</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>INSERM U289, Physiopathologie et Pathogenèse des Maladies Dégénératives du Système Nerveux, Hoˆpital de la Salpêtrière, 47 bd de l'Hoˆpital, 75013 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Neuroscience</title><title level="j" type="abbrev">NSC</title><idno type="ISSN">0306-4522</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1995">1995</date><biblScope unit="volume">72</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="355">355</biblScope><biblScope unit="page" to="363">363</biblScope></imprint><idno type="ISSN">0306-4522</idno></series><idno type="istex">B157D8785BAACB7BB3EC52E539A7FBA2A93B5D7C</idno><idno type="DOI">10.1016/0306-4522(95)00578-1</idno><idno type="PII">0306-4522(95)00578-1</idno><idno type="ArticleID">95005781</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0306-4522</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>A8</term><term>IFNγ</term><term>ILI-β</term><term>NADPH</term><term>NADPH-diaphorase</term><term>NGS</term><term>NO</term><term>NOS</term><term>O2−</term><term>ONOO−</term><term>PBS</term><term>PD</term><term>SN</term><term>SNpc</term><term>TBS</term><term>TNF-α</term><term>VTA</term><term>dopamine</term><term>eNOS</term><term>human</term><term>iNOS</term><term>mesencephalon</term><term>nNOS</term><term>neurodegeneration</term><term>nitric oxide</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Parkinson's disease is characterized by a loss of dopaminergic neurons in the mesencephalon. Although the mechanism of this neuronal loss is still unknown, oxidative stress is very likely involved in the cascade of events leading to nerve cell death. Since nitric oxide could be involved in the production of free radicals, we analysed, using immunohistochemistry and histochemistry, the production systems of nitric oxide in the mesencephalon of four patients with idiopathic Parkinson's disease and three matched control subjects. Using specific antibodies directed against the inducible isoform of nitric oxide synthase (the enzyme involved in the synthesis of nitric oxide), we found evidence to suggest that this isoform was present solely in glial cells displaying the morphological characteristics of activated macrophages. Immunohistochemical analysis performed with antibodies against the neuronal isoform of nitric oxide synthase, however, revealed perikarya and processes of neurons but no glial cell staining. The number of nitric oxide synthase-containing cells was investigated by histoenzymology, using the NADPH-diaphorase activity of nitric oxide synthase. Histochemistry revealed (i) a significant increase in NADPH-diaphorasepositive glial cell density in the dopaminergic cell groups characterized by neuronal loss in Parkinson's disease and (ii) a neuronal loss in Parkinson's disease that was two-fold greater for pigmented NADPH-diaphorase-negative neurons than for pigmented NADPH-diaphorase-positive neurons.These data suggest a potentially deleterious role of glial cells producing excessive levels of nitric oxide in Parkinson's disease, which may be neurotoxic for a subpopulation of dopaminergic neurons, especially those not expressing NADPH-diaphorase activity. However, it cannot be excluded that the presence of glial cells expressing nitric oxide synthase in the substantia nigra of patients with Parkinson's disease represents a consequence of dopaminergic neuronal loss.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement><orgName><li>Hôpital de la Salpêtrière</li></orgName></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Hunot, S" sort="Hunot, S" uniqKey="Hunot S" first="S." last="Hunot">S. Hunot</name></region><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Yves Agid</name><name sortKey="Boissiere, F" sort="Boissiere, F" uniqKey="Boissiere F" first="F." last="Boissière">F. Boissière</name><name sortKey="Brugg, B" sort="Brugg, B" uniqKey="Brugg B" first="B." last="Brugg">B. Brugg</name><name sortKey="Faucheux, B" sort="Faucheux, B" uniqKey="Faucheux B" first="B." last="Faucheux">B. Faucheux</name><name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E. C." last="Hirsch">E. C. Hirsch</name><name sortKey="Mouatt Prigent, A" sort="Mouatt Prigent, A" uniqKey="Mouatt Prigent A" first="A." last="Mouatt-Prigent">A. Mouatt-Prigent</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002155 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002155 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B157D8785BAACB7BB3EC52E539A7FBA2A93B5D7C
|texte= Nitric oxide synthase and neuronal vulnerability in parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |